Immunomodulatory effect of mesenchymal stem cells
Mesenchymal stem cells represent an adult population ofnonhematopoietic cells, which can differentiate into a variety of celltypes such as osteocytes, chondrocytes, adipocytes, and myocytes.They display immunomodulatory properties that have led to theconsideration of their use for the inhibition of...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Instituto Israelita de Ensino e Pesquisa Albert Einstein
2011-06-01
|
Series: | Einstein (São Paulo) |
Subjects: | |
Online Access: | http://apps.einstein.br/revista/arquivos/PDF/1843-Einstein_v9n2_224-228.pdf |
id |
doaj-3a10ae6d2a134390b21ac103fb2670a3 |
---|---|
record_format |
Article |
spelling |
doaj-3a10ae6d2a134390b21ac103fb2670a32020-11-24T23:06:31ZengInstituto Israelita de Ensino e Pesquisa Albert EinsteinEinstein (São Paulo)1679-45082011-06-0192224228Immunomodulatory effect of mesenchymal stem cellsLuciana Cavalheiro MartiAndreza Alice Feitosa RibeiroNelson HamerschlakMesenchymal stem cells represent an adult population ofnonhematopoietic cells, which can differentiate into a variety of celltypes such as osteocytes, chondrocytes, adipocytes, and myocytes.They display immunomodulatory properties that have led to theconsideration of their use for the inhibition of immune responses. Inthis context, mesenchymal stem cells efficiently inhibit maturation,cytokine production, and the T cell stimulatory capacity of dendriticcells. They also can impair proliferation, cytokine secretion, andcytotoxic potential of T lymphocytes. Moreover, mesenchymal stem cells are able to inhibit the differentiation of B cells to plasma cells by inhibiting their capacity to produce antibodies. A variety of animal models confirm the immunomodulatory properties of mesenchymal stem cells. Clinical studies including patients withsevere acute graft-versus-host disease have revealed that theadministration of mesenchymal stem cells results in significantclinical responses. Therefore, mesenchymal stem cells improve acutegraft-versus-host disease and represent a promising candidate for theprevention and treatment of immune-mediated diseases, due to theirimmunomodulatory capability and their low immunogenicity.http://apps.einstein.br/revista/arquivos/PDF/1843-Einstein_v9n2_224-228.pdfMesenchymal stem cellsImmunomodulation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Luciana Cavalheiro Marti Andreza Alice Feitosa Ribeiro Nelson Hamerschlak |
spellingShingle |
Luciana Cavalheiro Marti Andreza Alice Feitosa Ribeiro Nelson Hamerschlak Immunomodulatory effect of mesenchymal stem cells Einstein (São Paulo) Mesenchymal stem cells Immunomodulation |
author_facet |
Luciana Cavalheiro Marti Andreza Alice Feitosa Ribeiro Nelson Hamerschlak |
author_sort |
Luciana Cavalheiro Marti |
title |
Immunomodulatory effect of mesenchymal stem cells |
title_short |
Immunomodulatory effect of mesenchymal stem cells |
title_full |
Immunomodulatory effect of mesenchymal stem cells |
title_fullStr |
Immunomodulatory effect of mesenchymal stem cells |
title_full_unstemmed |
Immunomodulatory effect of mesenchymal stem cells |
title_sort |
immunomodulatory effect of mesenchymal stem cells |
publisher |
Instituto Israelita de Ensino e Pesquisa Albert Einstein |
series |
Einstein (São Paulo) |
issn |
1679-4508 |
publishDate |
2011-06-01 |
description |
Mesenchymal stem cells represent an adult population ofnonhematopoietic cells, which can differentiate into a variety of celltypes such as osteocytes, chondrocytes, adipocytes, and myocytes.They display immunomodulatory properties that have led to theconsideration of their use for the inhibition of immune responses. Inthis context, mesenchymal stem cells efficiently inhibit maturation,cytokine production, and the T cell stimulatory capacity of dendriticcells. They also can impair proliferation, cytokine secretion, andcytotoxic potential of T lymphocytes. Moreover, mesenchymal stem cells are able to inhibit the differentiation of B cells to plasma cells by inhibiting their capacity to produce antibodies. A variety of animal models confirm the immunomodulatory properties of mesenchymal stem cells. Clinical studies including patients withsevere acute graft-versus-host disease have revealed that theadministration of mesenchymal stem cells results in significantclinical responses. Therefore, mesenchymal stem cells improve acutegraft-versus-host disease and represent a promising candidate for theprevention and treatment of immune-mediated diseases, due to theirimmunomodulatory capability and their low immunogenicity. |
topic |
Mesenchymal stem cells Immunomodulation |
url |
http://apps.einstein.br/revista/arquivos/PDF/1843-Einstein_v9n2_224-228.pdf |
work_keys_str_mv |
AT lucianacavalheiromarti immunomodulatoryeffectofmesenchymalstemcells AT andrezaalicefeitosaribeiro immunomodulatoryeffectofmesenchymalstemcells AT nelsonhamerschlak immunomodulatoryeffectofmesenchymalstemcells |
_version_ |
1725622604612501504 |